Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Sanjay Hake"'
Autor:
Sanjay Hake, Tapankumar Shah
Publikováno v:
Perspectives in Clinical Research, Vol 2, Iss 3, Pp 105-108 (2011)
Negotiation as a skill is a key requirement for each and every job profile where dealing with multiple parties is involved. The important focus while negotiating should be on the interest then position. Key to every successful negotiation is advance
Externí odkaz:
https://doaj.org/article/1eea702c2521445c8bb17ab2b16ce30c
Autor:
Glen Wunderlich, Zuzana Blahova, Sanjay Hake, Satoru Ikezawa, Stephen Marder, Peter Falkai, John H. Krystal
Publikováno v:
CNS Spectrums. 28:229-229
IntroductionCognitive impairment is a major determinant of poor functional outcome in schizophrenia and there are currently no available pharmacotherapies. Deficits in glutamatergic signaling play a key role in the neuropathology of cognitive symptom
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6d2d5e6668847ca9c95b73b8820a0c00
https://doi.org/10.1017/s1092852923001530
https://doi.org/10.1017/s1092852923001530
Autor:
Yihua Zhao, W. Wolfgang Fleischhacker, Stephane Pollentier, Richard S.E. Keefe, Martina Gröschl, Emilio Mantero-Atienza, Jana Podhorna, Michael Desch, Sanjay Hake, David P. Walling, Songqiao Huang, Ronald Brenner, Kazuyuki Nakagome
Publikováno v:
The Lancet Psychiatry. 8:191-201
Summary Background Cognitive impairment associated with schizophrenia predicts poor functional outcomes, but currently no approved pharmacotherapy is available. This study investigated whether the glycine transporter-1 inhibitor BI 425809 improves co
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2feb699218895dfd05c4387e16c469cb
https://doi.org/10.1016/s2215-0366(20)30513-7
https://doi.org/10.1016/s2215-0366(20)30513-7
Autor:
Sanjay Hake, Jana Podhorna, Martina Groeschl, Stephane Pollentier, Richard S.E. Keefe, Alexandra S. Atkins
BACKGROUND: Cognitive impairment is a core feature of schizophrenia and a major determinant of poor functional outcome, but no pharmacological treatment is currently approved for this aspect of the disease. N-methyl-D-aspartate (NMDA) receptor hypofu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c566461d2127fe2ba012e190a5dbe1d4
https://europepmc.org/articles/PMC6455677/
https://europepmc.org/articles/PMC6455677/
Publikováno v:
Schizophrenia Bulletin
Background There are currently no approved medications for cognition in patients with schizophrenia. BI 425809, a glycine transporter 1 inhibitor, increases glycine in the synaptic cleft and may improve glutamatergic neurotransmission, synaptic neuro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::042172ee547d0e5ef6077c113e9ab16a
https://doi.org/10.1093/schbul/sbaa031.106
https://doi.org/10.1093/schbul/sbaa031.106
Publikováno v:
Perspectives in Clinical Research, Vol 6, Iss 1, Pp 15-19 (2015)
Perspectives in Clinical Research
Perspectives in Clinical Research
Respiratory studies are complex on account of specific therapeutic knowledge that is needed and various instruments that are used for the management of this condition. Monitoring a respiratory study requires knowledge of the specific disease and asso
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::49cbb242306ae5a375f554269f4fa441
https://doi.org/10.4103/2229-3485.148798
https://doi.org/10.4103/2229-3485.148798